Basic Study of Combination Therapy Based on APCC-induced FVllI Activation in Hemophilia A Patients With Inhibitors
Condition(s):Hemophilia A With InhibitorLast Updated:September 18, 2015Unknown status
Hide Studies Not Open or Pending
Condition(s):Hemophilia A With InhibitorLast Updated:September 18, 2015Unknown status
Condition(s):Healthy Volunteers; Haemophilia A With or Without InhibitorsLast Updated:November 14, 2022Active, not recruiting
Condition(s):Hemophilia ALast Updated:June 28, 2012Withdrawn
Condition(s):Von Willebrand Disease; Blood Coagulation Disorders; Blood Platelet Disorders; Hematologic DiseaseLast Updated:February 11, 2011Completed
Condition(s):Severe Hemophilia ALast Updated:April 8, 2022Terminated
Condition(s):Hemophilia ALast Updated:March 5, 2021Not yet recruiting
Condition(s):Hemophilia A; Hemophilia BLast Updated:September 21, 2021Enrolling by invitation
Condition(s):HemophiliaLast Updated:February 1, 2022Recruiting
Condition(s):Hemophilia ALast Updated:June 2, 2021Completed
Condition(s):Hemophilia ALast Updated:August 24, 2017Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.